This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Small Molecule Drugs for Atopic Dermatitis, Rheumatoid Arthritis, and Hereditary Angioedema

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Considerations for Transition From Subcutaneous to Oral Prophylaxis in the Treatment of Hereditary Angioedema

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Attenuated Androgen Discontinuation in Patients with Hereditary Angioedema: a Commented Case Series

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Assessment and Management of Disease Burden and Quality of Life in Patients with Hereditary Angioedema: a Consensus Report

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Long-Term Prophylaxis in Hereditary Angioedema Management: Current Practices in France and Unmet Needs

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Shared Decision-Making in the Management of Hereditary Angioedema: An Analysis of Patient and Physician Perspectives

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Global Perceptions of the Current and Future Impacts of COVID-19 on Hereditary Angioedema Management

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Berotralstat (BCX7353) is a Novel, Oral Prophylactic Treatment for Hereditary Angioedema: Review of Phase II and III Studies

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Androgen Use in Hereditary Angioedema: A Critical Appraisal and Approaches to Transitioning from Androgens to Other Therapies

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Oral Berotralstat for the Prophylaxis of Hereditary Angioedema Attacks in Patients in Japan: A Phase 3 Randomized Trial

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
Previous Page
1 2 3 4 5 6 … 9
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional